209 related articles for article (PubMed ID: 30181180)
21. Down-regulated miR-26a promotes proliferation, migration, and invasion
Yang C; Zheng S; Liu T; Liu Q; Dai F; Zhou J; Chen Y; Sheyhidin I; Lu X
FASEB J; 2017 May; 31(5):2114-2122. PubMed ID: 28174206
[TBL] [Abstract][Full Text] [Related]
22. The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.
Kikuchi A; Fumoto K; Kimura H
Br J Pharmacol; 2017 Dec; 174(24):4651-4665. PubMed ID: 28514532
[TBL] [Abstract][Full Text] [Related]
23. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
25. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
26. Targeting HOX/PBX dimer formation as a potential therapeutic option in esophageal squamous cell carcinoma.
Shen LY; Zhou T; Du YB; Shi Q; Chen KN
Cancer Sci; 2019 May; 110(5):1735-1745. PubMed ID: 30844117
[TBL] [Abstract][Full Text] [Related]
27. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
[TBL] [Abstract][Full Text] [Related]
28. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
30. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
31. RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.
Xiang G; Yi Y; Weiwei H; Weiming W
Tumour Biol; 2016 Jan; 37(1):773-9. PubMed ID: 26250459
[TBL] [Abstract][Full Text] [Related]
32. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
34. LINC00152 facilitates tumorigenesis in esophageal squamous cell carcinoma via miR-153-3p/FYN axis.
Liu D; Gao M; Wu K; Zhu D; Yang Y; Zhao S
Biomed Pharmacother; 2019 Apr; 112():108654. PubMed ID: 30784933
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo.
Okumura T; Shimada Y; Moriyama M; Takei Y; Omura T; Sekine S; Nagata T; Shimizu K; Tsukada K
Int J Oncol; 2014 Jun; 44(6):1923-32. PubMed ID: 24692008
[TBL] [Abstract][Full Text] [Related]
37. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-340 Inhibits Esophageal Cancer Cell Growth and Invasion by Targeting Phosphoserine Aminotransferase 1.
Yan S; Jiang H; Fang S; Yin F; Wang Z; Jia Y; Sun X; Wu S; Jiang T; Mao A
Cell Physiol Biochem; 2015; 37(1):375-86. PubMed ID: 26316084
[TBL] [Abstract][Full Text] [Related]
39. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q
PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985
[TBL] [Abstract][Full Text] [Related]
40. CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy.
Kimura H; Yamamoto H; Harada T; Fumoto K; Osugi Y; Sada R; Maehara N; Hikita H; Mori S; Eguchi H; Ikawa M; Takehara T; Kikuchi A
Clin Cancer Res; 2019 Mar; 25(6):1936-1947. PubMed ID: 30610103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]